
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Auteur Andrea L. HOWARD
|
|
Documents disponibles écrits par cet auteur (3)
Faire une suggestion Affiner la rechercheDefining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity / Margaret H. SIBLEY in Journal of Child Psychology and Psychiatry, 58-6 (June 2017)
![]()
[article]
Titre : Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity Type de document : texte imprimé Auteurs : Margaret H. SIBLEY, Auteur ; James M. SWANSON, Auteur ; L. Eugene ARNOLD, Auteur ; Lily HECHTMAN, Auteur ; Elizabeth B. OWENS, Auteur ; Annamarie STEHLI, Auteur ; Howard B. ABIKOFF, Auteur ; Stephen P. HINSHAW, Auteur ; Brooke S.G. MOLINA, Auteur ; John T. MITCHELL, Auteur ; Peter S. JENSEN, Auteur ; Andrea L. HOWARD, Auteur ; Kimberley D. LAKES, Auteur ; William E. PELHAM, Auteur ; THE MTA COOPERATIVE GROUP, Auteur Article en page(s) : p.655-662 Langues : Anglais (eng) Mots-clés : Adult ADHD DSM-5 diagnosis Index. décimale : PER Périodiques Résumé : Objective Longitudinal studies of children diagnosed with ADHD report widely ranging ADHD persistence rates in adulthood (5–75%). This study documents how information source (parent vs. self-report), method (rating scale vs. interview), and symptom threshold (DSM vs. norm-based) influence reported ADHD persistence rates in adulthood. Method Five hundred seventy-nine children were diagnosed with DSM-IV ADHD-Combined Type at baseline (ages 7.0–9.9 years) 289 classmates served as a local normative comparison group (LNCG), 476 and 241 of whom respectively were evaluated in adulthood (Mean Age = 24.7). Parent and self-reports of symptoms and impairment on rating scales and structured interviews were used to investigate ADHD persistence in adulthood. Results Persistence rates were higher when using parent rather than self-reports, structured interviews rather than rating scales (for self-report but not parent report), and a norm-based (NB) threshold of 4 symptoms rather than DSM criteria. Receiver-Operating Characteristics (ROC) analyses revealed that sensitivity and specificity were optimized by combining parent and self-reports on a rating scale and applying a NB threshold. Conclusion The interview format optimizes young adult self-reporting when parent reports are not available. However, the combination of parent and self-reports from rating scales, using an ‘or’ rule and a NB threshold optimized the balance between sensitivity and specificity. With this definition, 60% of the ADHD group demonstrated symptom persistence and 41% met both symptom and impairment criteria in adulthood. En ligne : http://dx.doi.org/10.1111/jcpp.12620 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=308
in Journal of Child Psychology and Psychiatry > 58-6 (June 2017) . - p.655-662[article] Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity [texte imprimé] / Margaret H. SIBLEY, Auteur ; James M. SWANSON, Auteur ; L. Eugene ARNOLD, Auteur ; Lily HECHTMAN, Auteur ; Elizabeth B. OWENS, Auteur ; Annamarie STEHLI, Auteur ; Howard B. ABIKOFF, Auteur ; Stephen P. HINSHAW, Auteur ; Brooke S.G. MOLINA, Auteur ; John T. MITCHELL, Auteur ; Peter S. JENSEN, Auteur ; Andrea L. HOWARD, Auteur ; Kimberley D. LAKES, Auteur ; William E. PELHAM, Auteur ; THE MTA COOPERATIVE GROUP, Auteur . - p.655-662.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 58-6 (June 2017) . - p.655-662
Mots-clés : Adult ADHD DSM-5 diagnosis Index. décimale : PER Périodiques Résumé : Objective Longitudinal studies of children diagnosed with ADHD report widely ranging ADHD persistence rates in adulthood (5–75%). This study documents how information source (parent vs. self-report), method (rating scale vs. interview), and symptom threshold (DSM vs. norm-based) influence reported ADHD persistence rates in adulthood. Method Five hundred seventy-nine children were diagnosed with DSM-IV ADHD-Combined Type at baseline (ages 7.0–9.9 years) 289 classmates served as a local normative comparison group (LNCG), 476 and 241 of whom respectively were evaluated in adulthood (Mean Age = 24.7). Parent and self-reports of symptoms and impairment on rating scales and structured interviews were used to investigate ADHD persistence in adulthood. Results Persistence rates were higher when using parent rather than self-reports, structured interviews rather than rating scales (for self-report but not parent report), and a norm-based (NB) threshold of 4 symptoms rather than DSM criteria. Receiver-Operating Characteristics (ROC) analyses revealed that sensitivity and specificity were optimized by combining parent and self-reports on a rating scale and applying a NB threshold. Conclusion The interview format optimizes young adult self-reporting when parent reports are not available. However, the combination of parent and self-reports from rating scales, using an ‘or’ rule and a NB threshold optimized the balance between sensitivity and specificity. With this definition, 60% of the ADHD group demonstrated symptom persistence and 41% met both symptom and impairment criteria in adulthood. En ligne : http://dx.doi.org/10.1111/jcpp.12620 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=308 Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study / Brooke S.G. MOLINA in Journal of Child Psychology and Psychiatry, 59-6 (June 2018)
![]()
[article]
Titre : Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study Type de document : texte imprimé Auteurs : Brooke S.G. MOLINA, Auteur ; Andrea L. HOWARD, Auteur ; James M. SWANSON, Auteur ; Annamarie STEHLI, Auteur ; John T. MITCHELL, Auteur ; Traci M. KENNEDY, Auteur ; Jeffery N. EPSTEIN, Auteur ; L. Eugene ARNOLD, Auteur ; Lily HECHTMAN, Auteur ; Benedetto VITIELLO, Auteur ; Betsy HOZA, Auteur Article en page(s) : p.692-702 Langues : Anglais (eng) Mots-clés : Adhd Attention deficit disorder adolescence drug abuse Index. décimale : PER Périodiques Résumé : BACKGROUND: Inconsistent findings exist regarding long-term substance use (SU) risk for children diagnosed with attention-deficit/hyperactivity disorder (ADHD). The observational follow-up of the Multimodal Treatment Study of Children with ADHD (MTA) provides an opportunity to assess long-term outcomes in a large, diverse sample. METHODS: Five hundred forty-seven children, mean age 8.5, diagnosed with DSM-IV combined-type ADHD and 258 classmates without ADHD (local normative comparison group; LNCG) completed the Substance Use Questionnaire up to eight times from mean age 10 to mean age 25. RESULTS: In adulthood, weekly marijuana use (32.8% ADHD vs. 21.3% LNCG) and daily cigarette smoking (35.9% vs. 17.5%) were more prevalent in the ADHD group than the LNCG. The cumulative record also revealed more early substance users in adolescence for ADHD (57.9%) than LNCG (41.9%), including younger first use of alcohol, cigarettes, marijuana, and illicit drugs. Alcohol and nonmarijuana illicit drug use escalated slightly faster in the ADHD group in early adolescence. Early SU predicted quicker SU escalation and more SU in adulthood for both groups. CONCLUSIONS: Frequent SU for young adults with childhood ADHD is accompanied by greater initial exposure at a young age and slightly faster progression. Early SU prevention and screening is critical before escalation to intractable levels. En ligne : http://dx.doi.org/10.1111/jcpp.12855 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=363
in Journal of Child Psychology and Psychiatry > 59-6 (June 2018) . - p.692-702[article] Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study [texte imprimé] / Brooke S.G. MOLINA, Auteur ; Andrea L. HOWARD, Auteur ; James M. SWANSON, Auteur ; Annamarie STEHLI, Auteur ; John T. MITCHELL, Auteur ; Traci M. KENNEDY, Auteur ; Jeffery N. EPSTEIN, Auteur ; L. Eugene ARNOLD, Auteur ; Lily HECHTMAN, Auteur ; Benedetto VITIELLO, Auteur ; Betsy HOZA, Auteur . - p.692-702.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 59-6 (June 2018) . - p.692-702
Mots-clés : Adhd Attention deficit disorder adolescence drug abuse Index. décimale : PER Périodiques Résumé : BACKGROUND: Inconsistent findings exist regarding long-term substance use (SU) risk for children diagnosed with attention-deficit/hyperactivity disorder (ADHD). The observational follow-up of the Multimodal Treatment Study of Children with ADHD (MTA) provides an opportunity to assess long-term outcomes in a large, diverse sample. METHODS: Five hundred forty-seven children, mean age 8.5, diagnosed with DSM-IV combined-type ADHD and 258 classmates without ADHD (local normative comparison group; LNCG) completed the Substance Use Questionnaire up to eight times from mean age 10 to mean age 25. RESULTS: In adulthood, weekly marijuana use (32.8% ADHD vs. 21.3% LNCG) and daily cigarette smoking (35.9% vs. 17.5%) were more prevalent in the ADHD group than the LNCG. The cumulative record also revealed more early substance users in adolescence for ADHD (57.9%) than LNCG (41.9%), including younger first use of alcohol, cigarettes, marijuana, and illicit drugs. Alcohol and nonmarijuana illicit drug use escalated slightly faster in the ADHD group in early adolescence. Early SU predicted quicker SU escalation and more SU in adulthood for both groups. CONCLUSIONS: Frequent SU for young adults with childhood ADHD is accompanied by greater initial exposure at a young age and slightly faster progression. Early SU prevention and screening is critical before escalation to intractable levels. En ligne : http://dx.doi.org/10.1111/jcpp.12855 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=363 Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression / James M. SWANSON in Journal of Child Psychology and Psychiatry, 58-6 (June 2017)
![]()
[article]
Titre : Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression Type de document : texte imprimé Auteurs : James M. SWANSON, Auteur ; L. Eugene ARNOLD, Auteur ; Brooke S.G. MOLINA, Auteur ; Margaret H. SIBLEY, Auteur ; Lily HECHTMAN, Auteur ; Stephen P. HINSHAW, Auteur ; Howard B. ABIKOFF, Auteur ; Annamarie STEHLI, Auteur ; Elizabeth B. OWENS, Auteur ; John T. MITCHELL, Auteur ; Quyen NICHOLS, Auteur ; Andrea L. HOWARD, Auteur ; Laurence L. GREENHILL, Auteur ; Betsy HOZA, Auteur ; Jeffrey H. NEWCORN, Auteur ; Peter S. JENSEN, Auteur ; Benedetto VITIELLO, Auteur ; Timothy WIGAL, Auteur ; Jeffery N. EPSTEIN, Auteur ; Leanne TAMM, Auteur ; Kimberly D. LAKES, Auteur ; James WAXMONSKY, Auteur ; Marc LERNER, Auteur ; Joy ETCOVITCH, Auteur ; Desiree W. MURRAY, Auteur ; Maximilian MUENKE, Auteur ; Maria T. ACOSTA, Auteur ; Mauricio ARCOS-BURGOS, Auteur ; William E. PELHAM, Auteur ; Helena C. KRAEMER, Auteur ; THE MTA COOPERATIVE GROUP, Auteur Article en page(s) : p.663-678 Langues : Anglais (eng) Mots-clés : Attention-deficit/hyperactivity disorder follow-up studies growth longitudinal studies treatment trials medication effects Index. décimale : PER Périodiques Résumé : Background The Multimodal Treatment Study (MTA) began as a 14-month randomized clinical trial of behavioral and pharmacological treatments of 579 children (7–10 years of age) diagnosed with attention-deficit/hyperactivity disorder (ADHD)-combined type. It transitioned into an observational long-term follow-up of 515 cases consented for continuation and 289 classmates (258 without ADHD) added as a local normative comparison group (LNCG), with assessments 2–16 years after baseline. Methods Primary (symptom severity) and secondary (adult height) outcomes in adulthood were specified. Treatment was monitored to age 18, and naturalistic subgroups were formed based on three patterns of long-term use of stimulant medication (Consistent, Inconsistent, and Negligible). For the follow-up, hypothesis-generating analyses were performed on outcomes in early adulthood (at 25 years of age). Planned comparisons were used to estimate ADHD-LNCG differences reflecting persistence of symptoms and naturalistic subgroup differences reflecting benefit (symptom reduction) and cost (height suppression) associated with extended use of medication. Results For ratings of symptom severity, the ADHD-LNCG comparison was statistically significant for the parent/self-report average (0.51 ± 0.04, p < .0001, d = 1.11), documenting symptom persistence, and for the parent/self-report difference (0.21 ± 0.04, p < .0001, d = .60), documenting source discrepancy, but the comparisons of naturalistic subgroups reflecting medication effects were not significant. For adult height, the ADHD group was 1.29 ± 0.55 cm shorter than the LNCG (p < .01, d = .21), and the comparisons of the naturalistic subgroups were significant: the treated group with the Consistent or Inconsistent pattern was 2.55 ± 0.73 cm shorter than the subgroup with the Negligible pattern (p < .0005, d = .42), and within the treated group, the subgroup with the Consistent pattern was 2.36 ± 1.13 cm shorter than the subgroup with the Inconsistent pattern (p < .04, d = .38). Conclusions In the MTA follow-up into adulthood, the ADHD group showed symptom persistence compared to local norms from the LNCG. Within naturalistic subgroups of ADHD cases, extended use of medication was associated with suppression of adult height but not with reduction of symptom severity. En ligne : http://dx.doi.org/10.1111/jcpp.12684 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=308
in Journal of Child Psychology and Psychiatry > 58-6 (June 2017) . - p.663-678[article] Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression [texte imprimé] / James M. SWANSON, Auteur ; L. Eugene ARNOLD, Auteur ; Brooke S.G. MOLINA, Auteur ; Margaret H. SIBLEY, Auteur ; Lily HECHTMAN, Auteur ; Stephen P. HINSHAW, Auteur ; Howard B. ABIKOFF, Auteur ; Annamarie STEHLI, Auteur ; Elizabeth B. OWENS, Auteur ; John T. MITCHELL, Auteur ; Quyen NICHOLS, Auteur ; Andrea L. HOWARD, Auteur ; Laurence L. GREENHILL, Auteur ; Betsy HOZA, Auteur ; Jeffrey H. NEWCORN, Auteur ; Peter S. JENSEN, Auteur ; Benedetto VITIELLO, Auteur ; Timothy WIGAL, Auteur ; Jeffery N. EPSTEIN, Auteur ; Leanne TAMM, Auteur ; Kimberly D. LAKES, Auteur ; James WAXMONSKY, Auteur ; Marc LERNER, Auteur ; Joy ETCOVITCH, Auteur ; Desiree W. MURRAY, Auteur ; Maximilian MUENKE, Auteur ; Maria T. ACOSTA, Auteur ; Mauricio ARCOS-BURGOS, Auteur ; William E. PELHAM, Auteur ; Helena C. KRAEMER, Auteur ; THE MTA COOPERATIVE GROUP, Auteur . - p.663-678.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 58-6 (June 2017) . - p.663-678
Mots-clés : Attention-deficit/hyperactivity disorder follow-up studies growth longitudinal studies treatment trials medication effects Index. décimale : PER Périodiques Résumé : Background The Multimodal Treatment Study (MTA) began as a 14-month randomized clinical trial of behavioral and pharmacological treatments of 579 children (7–10 years of age) diagnosed with attention-deficit/hyperactivity disorder (ADHD)-combined type. It transitioned into an observational long-term follow-up of 515 cases consented for continuation and 289 classmates (258 without ADHD) added as a local normative comparison group (LNCG), with assessments 2–16 years after baseline. Methods Primary (symptom severity) and secondary (adult height) outcomes in adulthood were specified. Treatment was monitored to age 18, and naturalistic subgroups were formed based on three patterns of long-term use of stimulant medication (Consistent, Inconsistent, and Negligible). For the follow-up, hypothesis-generating analyses were performed on outcomes in early adulthood (at 25 years of age). Planned comparisons were used to estimate ADHD-LNCG differences reflecting persistence of symptoms and naturalistic subgroup differences reflecting benefit (symptom reduction) and cost (height suppression) associated with extended use of medication. Results For ratings of symptom severity, the ADHD-LNCG comparison was statistically significant for the parent/self-report average (0.51 ± 0.04, p < .0001, d = 1.11), documenting symptom persistence, and for the parent/self-report difference (0.21 ± 0.04, p < .0001, d = .60), documenting source discrepancy, but the comparisons of naturalistic subgroups reflecting medication effects were not significant. For adult height, the ADHD group was 1.29 ± 0.55 cm shorter than the LNCG (p < .01, d = .21), and the comparisons of the naturalistic subgroups were significant: the treated group with the Consistent or Inconsistent pattern was 2.55 ± 0.73 cm shorter than the subgroup with the Negligible pattern (p < .0005, d = .42), and within the treated group, the subgroup with the Consistent pattern was 2.36 ± 1.13 cm shorter than the subgroup with the Inconsistent pattern (p < .04, d = .38). Conclusions In the MTA follow-up into adulthood, the ADHD group showed symptom persistence compared to local norms from the LNCG. Within naturalistic subgroups of ADHD cases, extended use of medication was associated with suppression of adult height but not with reduction of symptom severity. En ligne : http://dx.doi.org/10.1111/jcpp.12684 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=308

